Lloyd Price

SEPTEMBER 2, 2023

Exec Summary: The European HealthTech M&A market is expected to remain active in 2023, albeit with some slowdown from the record-breaking levels seen in 2022. This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies.

Life Science 64

Life Science Digital Health EHR BioTech 64

Lloyd Price

SEPTEMBER 16, 2023

Exec Summary: Investment into the Scottish healthtech market in 2022 reached a record high of £705 million, surpassing the previous record of £626 million set in 2021. The company raised $10m in 2022. This represents a year-on-year increase of 12%. Resolution Therapeutics is a spin-out of the University of Edinburgh.

Life Science 67

Life Science Digital Health BioTech Health Technology 67

Lloyd Price

FEBRUARY 13, 2024

Source: [link] Scotland's top ten tech start-ups - HealthTech related companies Investment into the Scottish healthtech market in 2022 reached a record high of £705 million, surpassing the previous record of £626 million set in 2021. At the top is Glasgow-based Amphista Therapeutics, which raised $50m in 2022.

Healthcare Innovation 64

Healthcare Innovation Digital Health Life Science healthcare technology 64

Digital Health Global

NOVEMBER 20, 2023

.–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. The technologies have already been used in the successful delivery of multiple AstraZeneca-sponsored clinical trials in over 40 countries.

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88